Mpox, previously known as monkeypox, is an infectious disease caused by monkeypox virus (MPXV), an Orthopoxvirus. The World Health Organization (WHO) adopted “mpox” as the preferred term for the disease in 2022, replacing “monkeypox.”
The virus has two major clades: clade I (subclades Ia and Ib) and clade II (subclades IIa and IIb). Mpox can spread through close contact with an infected person, including contact with skin or mucosal lesions, bodily fluids, respiratory particles and contaminated materials. In areas where the virus circulates in animals, it can also be transmitted from infected animals to humans.
A global outbreak caused primarily by clade IIb began in 2022, resulting in sustained person-to-person transmission across multiple regions. Clade I outbreaks have also occurred, particularly in Central and East Africa, and clade Ib has subsequently been detected in other countries.
Quick Overview
Symptoms
Symptoms include fever, headache, swollen glands, and exhaustion, followed by a painful, blistering rash. Please contact our Specialists if you notice any unusual sores.
Causes
Mpox is caused by monkeypox virus (MPXV) and spreads mainly through close contact, particularly skin-to-skin contact with lesions, scabs or bodily fluids.
Diagnosis
Diagnosis involves our Specialists taking a swab of your skin lesions or rash for laboratory PCR testing to confirm if the virus is present.Our specialists diagnose donovanosis by examining the area and taking a tissue sample or appropriate specimen for laboratory testing to confirm the diagnosis.
Treatment
Treatment is mostly supportive, including rest and paracetamol. Severe cases may require antivirals or hospital care. Our Specialists can provide guidance on managing symptoms.
Prevention
Prevent mpox by avoiding close contact with infected people, considering vaccination if eligible through NHS sexual health services, and practising good hygiene.
Prognosis
Most people recover within 2–4 weeks. Severity varies by clade and individual risk factors; pregnant people, children and immunocompromised people may develop severe disease.
Fees
STI Consultation (included in tests)
Consultation - £80
Mpox DNA PCR (Results in 4 Working Days)
£180
Mpox Vaccine
Refer to the NHS
FAQs
Symptoms can include:
• rash or skin lesions
• fever
• headache
• muscle aches
• backache
• swollen glands
• chills
• exhaustion
• sore throat
• joint pain
• rectal or anal pain, including proctitis
• mouth or throat lesions
Symptoms vary between people. The rash or lesions may occur without other symptoms, may be limited to one area such as the genitals, anus or mouth, and may appear at different stages of infection.
Mpox can resemble other conditions that cause skin or genital lesions, including herpes simplex virus (HSV), chickenpox (varicella-zoster virus), molluscum contagiosum and other rashes. Lesions may be few or solitary rather than occurring in clusters, and can appear on different parts of the body, including the genitals, perianal area, mouth or face.
Yes. Asymptomatic or subclinical mpox infection can occur, although its frequency and contribution to transmission are uncertain.
Most people recover without serious complications, but mpox can sometimes cause complications such as secondary bacterial infection, severe pain or proctitis, dehydration, eye disease and encephalitis. Severe disease is more likely in people who are immunocompromised, pregnant people and young children. Scarring may also occur after lesions heal.
Symptoms generally develop 5–21 days after exposure, commonly around 6–13 days. However, lesions may be the first or only symptom and do not necessarily follow fever or other systemic symptoms. If you develop symptoms after a possible exposure, contact a healthcare provider or sexual health clinic for advice and call ahead before attending in person.
Mpox is caused by monkeypox virus (MPXV). It spreads mainly through close physical contact, particularly contact with lesions, scabs or bodily fluids. It can also spread through contaminated materials such as bedding, towels and clothing.
The main risk factor is close physical contact with someone who has mpox. Risk may be higher with new or multiple sexual partners, particularly in areas or networks where the virus is circulating. Sharing bedding, towels, or clothing with an infected person can also increase the risk.
You can reduce your risk by avoiding close physical or sexual contact with anyone who has symptoms or has been diagnosed with mpox. Vaccination is also recommended for some people at higher risk. Good hand hygiene and avoiding shared towels, bedding, and clothing can further reduce the risk.
Yes. Condoms can reduce the risk of some sexually transmitted infections, but they do not fully protect against mpox because the virus can spread through skin-to-skin contact with infected areas that are not covered by a condom.
Yes. Mpox can spread through close physical contact, including kissing, particularly when an infected person has lesions around the mouth or face. Prolonged close face-to-face contact may also contribute to transmission.
Yes. Mpox can spread through contaminated items such as bedding, towels, and clothing that have been in contact with an infected person's lesions. Avoid sharing these items with someone who has mpox.
There have been no confirmed cases of mpox transmission through blood transfusion. Blood donation is subject to safety measures to reduce any potential risk of transmission.
Mpox is usually diagnosed using a PCR test on a sample taken from a skin lesion, such as a rash, blister or scab. Depending on the presentation, samples may be taken from more than one lesion or site. The samples are sent to a laboratory to test for MPXV.
A PCR test is the main test used to diagnose mpox. A clinician usually takes a swab from a skin lesion, blister, or scab. Depending on your symptoms, a swab from another affected area may also be considered.
Diagnosis is based on your symptoms, examination, and any relevant exposure history, such as close contact with someone who has mpox. Because mpox can resemble other conditions, a PCR test from a lesion is usually needed to confirm the diagnosis.
Yes. Mpox can resemble conditions such as chickenpox, shingles, genital herpes, syphilis, molluscum contagiosum, and hand, foot and mouth disease. Testing may be needed to confirm the cause of a rash or lesions.
A physical examination can help assess symptoms, but laboratory testing is usually needed to confirm mpox. A PCR swab from a lesion is the main diagnostic test. Blood tests are not routinely used to diagnose an active infection.
No. A physical examination can identify signs that are suggestive of mpox, but other conditions can look similar. A PCR test is usually needed to confirm the diagnosis.
No. Mpox can look similar to several other conditions, so symptoms alone cannot reliably confirm the infection. If you develop a new or unexplained rash, blisters, or lesions, seek medical advice and follow local guidance on testing.
Most people with mpox make a full recovery within 2–4 weeks. Some may have temporary or lasting changes in skin pigmentation or scarring where lesions occurred. More serious complications are uncommon but can occur, particularly in people with weakened immune systems.
Previous mpox infection may provide some protection against future infection, but the duration and strength of this protection are not fully understood. Reinfection can occur, so continue to follow recommended prevention measures.
Reinfection is possible, so continue to reduce your risk of exposure after recovery. If you are eligible for mpox vaccination, vaccination can provide additional protection. Avoid close contact with anyone who has symptoms and follow current public health guidance.
It is important to inform recent close or sexual partners if they may have been exposed to mpox. This allows them to monitor for symptoms and seek appropriate medical advice or vaccination if recommended.
If you have mpox, avoid close physical and sexual contact with others until your lesions have completely healed and new skin has formed. Do not share towels, bedding, clothing, or other items that may have been contaminated, and practise good hand hygiene. Follow current public health guidance about sexual activity after recovery.
Yes. Mpox can be passed to a baby during pregnancy or through close contact during or after birth. Infection during pregnancy can lead to serious complications, so pregnant people who have been exposed or develop symptoms should seek medical advice promptly.
Mpox during pregnancy can cause more serious complications for both the pregnant person and baby. Infection may increase the risk of pregnancy loss, premature birth, or infection in the baby. If you are pregnant and have been exposed or develop symptoms, seek medical advice promptly.
Mpox during pregnancy is uncommon. However, because infection can cause complications for the pregnant person and baby, anyone who is pregnant and has been exposed or develops symptoms should seek medical advice promptly.
Treatment during pregnancy depends on the severity of mpox and individual circumstances. Most cases are managed with supportive care. People with severe illness or an increased risk of complications may be referred to NHS specialist services, where antiviral treatment may be considered. Treatment decisions during pregnancy should be made with the appropriate specialist healthcare team.
If you are pregnant, reduce your risk by avoiding close physical or sexual contact with anyone who has mpox symptoms or a new unexplained rash. Do not share towels, bedding, or clothing with someone who may be infected. If you have been exposed or develop symptoms, contact your midwife, maternity team, or GP promptly for advice.
Mpox may make postpartum recovery more difficult because of symptoms such as fever, fatigue, muscle aches and skin lesions. The main concern for a newborn is transmission through close contact, including contact with lesions. If you have active mpox, seek specialist maternity and paediatric advice about mother–baby contact, breastfeeding and expressed milk.
Page last reviewed by Mrs. Magdalena Nowacka on 24 September 2026 for general guidance only. It is not intended to replace the advice of your clinician.





